SPOTLIGHT -
October signals the beginning of flu immunization season, and expanded guidelines encourage the vaccination of even healthy young children.
Influenza, RSV, and COVID-19: Identifying determinants of hospitalization influence
The investigators concluded that age-related risk differences "highlight the necessity for tailored strategies, improving understanding of and treatment development for RVIs."
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Educational Intervention Could Prompt More Pediatric HPV Vaccine Initiation
An intervention applied at family care practices shows benefit to tailoring education to both clinicians and medical assistants.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
Discontinuing contact precautions for pediatric patients with methicillin-resistant Staphylococcus aureus
A pediatric health system discontinues MRSA contact precautions with sustained infection control success, supporting broader consideration while emphasizing the importance of horizontal prevention measures.
Sanofi and AstraZeneca plan on releasing 230,000 additional doses of nirsevimab-alip in January 2024
The unprecedented demand for nirsevimab-alip has resulted in a dramatic uptake in production of this RSV vaccine.